Companies›Services›Services›Commercial Services & Supplies

HEMO ORGANIC LIMITED

Services › Commercial Services & Supplies

Get alerts

Latest filings

Mon, 5 OctQmin Realities acquires 24.76 percent stake in Hemo Organic via preferential allotment · Ownership Changes
Mon, 5 OctVacro Enterprises acquires 17 lakh shares of Hemo Organic via preferential allotment · Ownership Changes
Sat, 3 OctBoard okays about 9x authorised capital hike, alters objects, appoints CS · Management Changes

All filings ↓

Ask Nexa about HEMO ORGANIC LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

A Commercial Services & Supplies company listed on BSE, reporting revenue of ₹1 Cr over the trailing twelve months.

Market Cap

₹—

P / E (TTM)

—

EV / EBITDA

—

Div Yield

—

Growth

158.8%▲

Revenue 5y CAGR

PAT — · EBITDA —

Quality

n/m·

ROCE · capital employed below zero

ROE n/m · margin -53.6%

Leverage

32.37·

Debt / Equity · high

Net debt ₹4.29 Cr

Revenue FY21→FY26

116.1×▲

Margin +516.2 pts

₹0 Cr → ₹1 Cr

Where it sits among 188 Trading & Distributors peersBar = share of peers beaten · tick = industry median · latest reported figures

ROCE#168/177

ROE#158/158

Debt / Equity#154/154

EBITDA margin#122/137

Revenue growth#99/135

Profit growth#137/157

Scorecard

Measured from the filed financials, judged against its Trading & Distributors peers · as of FY26 — not investment advice

Strengths

Revenue compounding 159% a year over 5 years

Concerns

Erratic profits — up in only 2 of the last 5 years

Carries more debt than its peers — 32.37× equity

higher than 100% of its 154 Trading & Distributors peers

Heavy working capital — 1138 days of cash tied up

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Governance

Is the board independent, clean and well-run?

Compliance

Did a company secretary sign off that it's clean?

Audit Report

What the auditor actually said — opinion, key audit matters, CARO clauses.

Earnings Call

What management said — and how it landed.

Investor Presentation

An AI read of the latest deck — verdict, KPIs, key slides and what it promised.

Events

Board meetings and results dates, upcoming and recent.

Reactions

How does the stock move after this company files?

Filings

The full disclosure feed.

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from HEMO ORGANIC LIMITED's filed financials and exchange disclosures

What does HEMO ORGANIC LIMITED do?

HEMO ORGANIC LIMITED is a Commercial Services & Supplies company listed on BSE.

Is HEMO ORGANIC LIMITED profitable?

No. Over the trailing twelve months HEMO ORGANIC LIMITED reported a net loss of ₹0.78 Cr on revenue of ₹0.93 Cr.

Does HEMO ORGANIC LIMITED pay a dividend?

Not in the latest reported year — HEMO ORGANIC LIMITED's dividend payout for FY26 was nil.

Is HEMO ORGANIC LIMITED debt-free?

No. It reported borrowings of ₹4.30 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹4.29 Cr after cash. Debt stands at 32.37× equity. That is higher than 100% of its 154 Trading & Distributors peers.

Where can I track HEMO ORGANIC LIMITED's announcements?

Every NSE and BSE filing by HEMO ORGANIC LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.